OPRX

OptimizeRx Corporation

Price

$7.75

return (12m)

-55.99%

p/e

31.60

p/bv

1.11

DIVIDEND YIELD

0.00%

OPRX price

OptimizeRx

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

21.09%

3 months

51.96%

1 year

-55.99%

2 years

-7.85%

5 years

-88.45%

10 years

124.64%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals OPRX

Valuation

P/E

31.60

Sector -0.28

Industry 3.22

P/BV

1.11

Sector 1.94

Industry 1.24

P/Revenue (PSR)

1.47

Sector 1.67

Industry 0.62

EV/EBITDA

Sector -55.30

Industry -75.48

EV/EBIT

Sector -488.87

Industry -4,101.67

P/EBITDA

Sector -185.04

Industry -448.58

P/EBIT

Sector -222.22

Industry -366.55

P/Total Assets

0.88

Sector 0.92

Industry 0.63

P/Net Current Assets

6.95

Sector -479.54

Industry -12.31

P/Working Capital

3.27

Sector -957.77

Industry -52.54

EPS

0.24

Sector -0.78

Industry -0.70

BVPS

6.90

Sector 3.74

Industry 5.07

Efficiency

Gross Margin

73.23%

Sector 48.28%

Industry 44.58%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -2.83%

EBIT Margin

0.00%

Sector -62.93%

Industry -2.71%

Operating Margin

11.05%

Sector -23.12%

Industry -9.09%

Net Profit Margins

4.66%

Sector -27.40%

Industry -17.11%

Asset Turnover

0.12

Sector 0.13

Industry 0.22

Profitability

ROE

3.51%

Sector -31.88%

Industry -50.42%

ROA

2.80%

Sector -28.23%

Industry -16.88%

ROIC

0.00%

Sector -315.71%

Industry -97.64%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.58

Sector 1.85

Industry 1.14

Net Debt / EBITDA

Sector -42.46

Industry -64.91

Net Debt / EBIT

Sector -37.26

Industry -4.38

Net Debt / Equity

0.14

Sector -1.04

Industry 0.20

Gross Debt / Equity

0.14

Sector -0.72

Industry 0.46

Equity/Assets

0.80

Sector 0.43

Industry 0.27

Liabilities/Assets

0.20

Sector 0.48

Industry 0.57

Growth

5Y Revenue CAGR

9.99%

Sector -

Industry -

5Y Earnings CAGR

65.54%

Sector -

Industry -

FAIR VALUE OF OptimizeRx ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$7.75

Fair Value

$6.10

Upside Return potential.

-21.24%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals OPRX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OPRX OptimizeRx Corporation	$7.75	-54.41%	0.00%	31.60	1.11	3.51%	4.66%
SLP Simulations Plus Inc.	$18.40	31.11%	0.00%	45.32	2.65	5.84%	9.90%
RVTY Revvity Inc.	$126.35	43.10%	0.22%	58.32	1.93	3.31%	8.22%
LLY Eli Lilly and Compay	$1,189.41	63.39%	0.52%	41.58	-	-%	33.53%
ISRG Intuitive Surgical Inc.	$370.42	-20.92%	0.00%	41.88	7.23	17.26%	28.62%
SNY Sanofi	$45.42	-5.82%	3.87%	7.43	1.37	18.43%	13.81%
NVS Novartis AG	$157.54	28.44%	1.96%	28.21	7.75	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$633.71	29.69%	0.29%	33.36	4.42	13.26%	15.08%
ABT Abbott Laboratories	$114.10	-11.22%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$92.02	4.02%	3.09%	24.60	2.36	9.59%	13.20%
GSK GlaxoSmithKline PLC	$51.43	35.71%	3.42%	15.92	4.50	28.24%	14.54%
BSX Boston Scientific Corp.	$48.17	-54.17%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$90.63	-21.17%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.44	-13.71%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$235.69	-16.49%	1.04%	22.12	5.18	23.41%	27.44%
DHR Danaher Corporation	$215.36	5.83%	0.67%	37.88	2.88	7.61%	15.95%
HCA HCA Healthcare Inc.	$427.16	6.75%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$294.37	225.27%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$27.00	1.68%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$329.67	-14.57%	1.06%	33.67	5.23	15.55%	14.43%
INMD InMode Ltd.	$14.93	2.47%	0.00%	11.50	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OPRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT OptimizeRx

OptimizeRx Corporation

Average Investor10 user rating

4.0 (0 people)

United States

20 years

Founded: 2006

2009

Time since IPO - 17 years

97

Employees

OptimizeRx Corporation (United States) is listed on the Nasdaq and has a market capitalization of $145.35 million, with shareholders equity totaling $131.08 million.

The company employs approximately 97 people and operates in the Health sector, within the Health Technology industry.

Over the past 12 months, OptimizeRx Corporation reported $98.65 million in revenue, generating net income of $4.60 million.

Key financial metrics include a P/E ratio of 31.60, a price-to-book (P/B) ratio of 1.11, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OPRX.

Market cap

$145.35 million

Net worth

$131.08 million

$131,080,000.00

Assets

$164.32 million

$164,320,000.00

Total Shares Outstanding

19.00 million

19,000,000

Average Daily Trading Volume

$338.04 Thousand

$338,041.42

Sector

Health

Industry

Health Technology

OPRX

OPRX revenue and profits

Financial Results OPRX

DRAG THE FRAME TO SEE MORE DATA

OPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$94.32 35,27% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$280.87 --3,76% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$65.47 127,01% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$391.06 33,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$45.42 --5,79% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,189.41 63,88% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$427.16 6,15% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$157.54 26,57% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75